Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe
Author(s) -
Dennis Nurjadi,
Adesola Olalekan,
Franziska Layer,
Adebayo Shittu,
Abraham Alabi,
Beniam Ghebremedhin,
Frieder Schaumburg,
Jonas Hofmann-Eifler,
P.J.J. Van Genderen,
Éric Caumes,
Ralf Fleck,
Frank P. Mockenhaupt,
Mathias Herrmann,
Winfried V. Kern,
Salim Abdulla,
Martin P. Grobusch,
Peter G. Kremsner,
Christiane Wolz,
Philipp Zanger
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku174
Subject(s) - colonization , staphylococcus aureus , trimethoprim , microbiology and biotechnology , biology , staphylococcal infections , antibiotic resistance , gene , antibiotics , bacteria , genetics
Co-trimoxazole (trimethoprim/sulfamethoxazole) is clinically valuable in treating skin and soft tissue infections (SSTIs) caused by community-associated methicillin-resistant Staphylococcus aureus (MRSA). The genetic basis of emerging trimethoprim/sulfamethoxazole resistance in S. aureus from Africa is unknown. Such knowledge is essential to anticipate its further spread. We investigated the molecular epidemiology of trimethoprim resistance in S. aureus collected in and imported from Africa.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom